HIV infections | |||||
Age | HIV infected | Per cent | |||
Shisana, 20146 31 | 15–24 | 720 000 | 7.1* | ||
Statistics South Africa, 201318 | 15–24 | 867 283 | 8.5 | ||
UNAIDS, 201318 19 | 10–19 | 320 000 | 3.1† | ||
Antiretroviral therapy | |||||
Age | HIV infected | On ART | Per cent | ||
Shisana, 20146 | 15–24 | 720 000 | 103 000 | 14 | |
Retention in care | |||||
Age | N | Retained | Per cent | End point | |
Maskew, 201229 | 18–29 | 1140 | 1018 | 89 | Retained 24 months |
Evans, 201326 | 15–24 | 1941 | 1252 | 65 | Retained 12 months |
Clouse, 201325 | 18–29 | 158 | 140 | 89 | Retained 12 months |
Peltzer, 201130 | 18–28 | 171 | 121 | 71 | Retained 12 months |
Fox, 201432 | 18–29 | 34 | 26 | 76 | Cross-sectional |
Laher, 201328 | 9–26 | 360 | 339 | 94 | Cross-sectional |
Boyles, 201133 | Adults | 1803 | 82 | Cross-sectional | |
Van Cutsem, 201034 | Adults | 6411 | 92 | Cross-sectional | |
Meta-analysis of retention | N | Retained | Per cent | ||
3604 | 2896 | 83% (95%CI 68% to 93%);I2=99% | |||
Viral suppression | |||||
Age | N | Suppressed | Per cent | End point‡ | |
Evans, 201326 | 15–24 | 1941 | 1813 | 93 | 6 months |
Nglazi, 201235 | 9–28 | 472 | 343 | 73 | 6 months |
Mutevedzi, 201136 | 16–24 | 808 | 696 | 86 | 12 months |
Brittain, 201537 | 9–14 | 305 | 227 | 75 | Cross-sectional |
Van Cutsem, 201038 | 10–24 | 546 | 414 | 76 | 12 months |
Lazarus, 201039 | 11–19 | 107 | 90 | 84 | Cross-sectional |
Maskew, 201229 | 18–29 | 1738 | 1407 | 81 | 6 months |
Laher, 201328 | 9–26 | 360 | 268 | 74 | Cross-sectional |
Davies, 2014*40 | 10–13 | 2161 | 1664 | 77 | Cross-sectional |
Meta-analysis of viral suppression | N | Retained | Per cent | ||
6227 | 5258 | 81% (95%CI 74% to 87%); I2=98% |
Bolded citations were included in meta-analysis.
*Calculated based on population data from 2012.
†Calculated based on population data from 2013.
‡Viral Suppression as Viral Load <400 copies/mL.